The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal. The document covers the management of unstable angina and all ...

Please provide your email address to receive an email when new articles are posted on . A guideline for managing patients with acute coronary syndrome was issued by several U.S. societies. The ...

MISSISSAUGA, ON, April 7, 2026 /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha(R) (evolocumab injection) for eligible ...

“Both the high safety standard and the risk [that] missed ACS poses to patients and clinicians contribute to over-testing, which exposes patients to costs and iatrogenic harm while contributing to ED ...

After being hospitalized for acute coronary syndrome (ACS), about 7% of patients die within a month of discharge, with up to a quarter facing readmission, often due to non-cardiac chest pain. Current ...

People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...

Objectives Physical activity (PA) provides protective effects against cardiovascular diseases, including ischaemic heart disease. However, recommending moderate to vigorous PA (MVPA) to patients with ...

Coronary artery disease (CAD) is the leading cause of death worldwide, with acute myocardial infarction (MI) representing the ...

PARIS — Adding the PCSK9 inhibitor evolocumab (Repatha, Amgen) to high-intensity statin therapy in the very high-risk setting of acute coronary syndrome (ACS) safely lowers low-density lipoprotein ...

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha® (evolocumab injection) for eligible patients following an acute coronary syndrome ...